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  Abstract 
    Background:   The type of neuroimaging for the evaluation of transient ischemic attack (TIA) 
is debatable. Many patients undergo head computed tomography (CT) with or without CT 
angiogram (CTA) while being at the emergency department (ED) and later magnetic reso-
nance imaging (MRI) with MR angiogram (MRA) during admission. We hypothesized that 
evaluation with only one imaging modality (CT/CTA or MRI/MRA) is sufficient to formulate a 
treatment plan. We looked for the most cost-effective way to evaluate TIA patients.   Methods:   
We performed a retrospective chart review of 82 patients with TIA. All patients had complete-
ly resolved neurological deficit at the time of their evaluation in the ED. We divided the pa-
tients into two groups. In group 1, the evaluation included CT with CTA of the head and neck. 
In group 2, the evaluation included brain MRI with MRA or CTA of the head and neck. We 
compared these two groups for clinical characteristics and etiological evaluations of stroke/
TIA. The outcomes were measured by the number of therapeutic adjustments for the preven-
tion of another ischemic stroke/TIA at the time of discharge from the hospital and revascu-
larization procedures. We counted the following as therapeutic adjustment: (1) antiplatelet 
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therapy was started de novo; (2) anticoagulation was started; (3) arterial revascularization 
procedure was performed, and (4) one antiplatelet agent was substituted for another. We 
performed a cost-effectiveness analysis if the outcomes of the two groups were different and 
a cost-minimization analysis if there was no difference in the outcomes. All cost calculations 
were made based on Medicare CPT codes.   Results:   Group 1 included 23 patients and group 
2 59 patients. The patients in both groups had similar demographic and clinical characteristics. 
There was no difference in other etiological evaluations in groups 1 and 2. All patients under-
went head CT as the first tool of evaluation whether MRI was done later or not. Therapeutic 
adjustments and revascularization procedures did not differ between the two groups. All head 
CTs showed no acute changes. MRI showed small ischemic infarcts in 44% of the patients in 
group 2. The average per-patient cost of neuroimaging with CT/CTA was USD 1,460.00, with 
CT and MRI/MRA USD 1,569 and with CT/CTA and brain MRI USD 2,090.00 (p < 0.01).   Conclu-
sion:   Either MRI/MRA or CT/CTA might be sufficient for the evaluation of patients with TIA or 
small asymptomatic strokes. If head CT at the ED is bypassed, a brain MRI with MRA of the 
head and neck would be the most informative tool at the lowest cost. Prospective studies with 
larger numbers of patients are needed for a better understanding of the safety and cost of 
imaging tools used for patients with TIA.    © 2014 S. Karger AG, Basel 
  Introduction 
  Patients with transient ischemic attack (TIA) often present to the emergency department 
(ED) when their symptoms have already improved   [1]  . A neurological examination is usually 
performed at baseline when patients are first evaluated by a physician. Head computed 
tomography (CT) is readily available from the ED and is frequently the first-choice test 
performed. Head CT is sensitive to exclude hemorrhage and shows clinically relevant ischemic 
infarcts in 4–13% of the patients with TIA   [2, 3]  . Nonvascular pathology (tumor, abscess or 
subdural hematoma) was identified on CT scans in 1–5% of the TIA patients in various series 
  [4, 5]  . Overall, CT provides limited information in most TIA patients. Including CT angiogram 
(CTA) of the head and neck into the evaluation helps diagnose vascular pathologies such as 
intracranial or extracranial stenosis   [6, 7]  . It can also easily be done at the ED but requires 
iodinated contrast and may therefore not be performed on subjects with renal problems or 
who have an allergy to contrast agents   [8]  . Magnetic resonance imaging (MRI) is the most 
sensitive tool for ischemia evaluation and considered by some to be the preferred method of 
evaluation for TIA patients   [9]  . It shows positive changes on diffusion-weighted MR images 
in 35–81% of the stroke patients initially diagnosed with TIA   [10–14]  . Like CTA, MR angiogram 
(MRA) of the head and neck provides information about vasculature pathology   [7]  . However, 
MRI/MRA often requires inpatient admission or much longer waiting time for evaluation 
given its limited availability.
    Therefore, it is becoming increasingly common practice that CT and MRI studies are often 
combined and sometimes duplicated in stroke/TIA diagnosis workup. At the ED, TIA patients 
undergo head CT or even CTA, and later, on admission, their workup is extended with MRI/
MRA. This combined approach in the evaluation of patients with TIA is redundant because 
both imaging modalities provide similar information. Furthermore, it exposes patients to 
unnecessary radiation with CT and incurs increased health-care cost.
    We hypothesized that evaluation with only one imaging modality (CT/CTA or MRI/MRA) 
is sufficient to formulate a treatment plan for patients with TIA. We performed this analysis 
to assess the clinical and cost-effectiveness (minimization) of CT- versus MRI-based neuro-
imaging evaluations in patients with TIA.71 Cerebrovasc Dis Extra 2014;4:69–76
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    Methods 
  We conducted a retrospective review of consecutive patients with TIA and small strokes 
but completely resolved neurological deficit who presented to the ED of the Beth Israel 
Deaconess Medical Center as ‘code stroke’ during a 2-year period from 2009 to 2010.
  Data  Collection  Procedure 
  The following information was retrieved from clinical charts: demographic data (age, 
gender, time from the onset of symptoms to ED presentation and symptoms duration); clinical 
characteristics (presence of diabetes mellitus, hypertension, hyperlipidemia, atrial fibril-
lation and congestive heart failure with an ejection fraction <30%); tests performed for an 
etiological evaluation of stroke/TIA (transthoracic and transesophageal echocardiogram, 
hemoglobin A1C and lipid panel); medications at presentation to the ED, new medications 
started upon initial evaluation at the ED or by hospital discharge; and length of hospital-
ization. We also retrieved the official interpretation of the imaging studies by the neuroradi-
ologists.
  Study  Groups 
  The patients were divided into two groups according to the neuroimaging evaluations. 
The evaluation in group 1 included head CT and head and neck CTA and in group 2 a brain 
MRI and either a head and neck CTA or MRA.
  Outcome  Measures 
  To assess the impact of imaging modalities on therapeutic decision-making, we deter-
mined the number of patients who had therapeutic adjustments made to their admission 
medications at the time of discharge based on MRI/MRA results. We considered the following 
as treatment adjustments: (1) antiplatelet therapy was started de novo; (2) anticoagulation 
was started; (3) arterial revascularization procedure was performed, and (4) one antiplatelet 
agent was substituted for another. We planned to perform a cost-effectiveness analysis if 
therapeutic adjustments or arterial revascularizations were different between the groups 
and a cost-minimization analysis if they were similar, based on CT and MRI CPT coding for 
Medicare in Boston, Mass., USA (  table 1  ).
  Statistical  Analysis 
  Analyses  were  performed  using  Microsoft  Excel  for  windows.  Categorical  variables 
(gender, presence of diabetes mellitus, hypertension, hyperlipidemia, atrial fibrillation and 
congestive heart failure) were statistically analyzed using χ  2   analysis, and continuous vari-
ables (age, blood pressure and cost of imaging tool) were analyzed using Student’s t test. 
Statistical significance was set at p < 0.05. 
Name of the test CPT codes Cost, USD
Head CT without contrast 70450 237
CTA head, including head C  T 70496 724
CTA neck 70948 736
CT perfusion 0042T 0
MRI of the brain without contrast 70551 630
MRA brain 70551 630
MRA neck with contrast 70548 702
  Table 1.   CPT codes for the 
evaluation of TIA patients and 
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    Results 
 Study  Groups 
  A total of 82 patients (45 men and 37 women) were included in the study. Baseline demo-
graphic and clinical characteristics are presented in   table 2  . All patients underwent head CT 
scanning at presentation at the ED as part of the hospital ‘code stroke’ protocol. Most of the 
patients came to the ED within 2–3 h of symptom onset. MRI was performed in 59 patients 
(group 2), and 23 patients were only evaluated with head CT (group 1). There was no 
difference in baseline demographic or clinical characteristics in patients who were or were 
not evaluated with MRI. There was also no difference in the length of stay or other etiological 
evaluations such as echocardiogram or lipid panel.
    Therapeutic Adjustments and Arterial Revascularization for TIA Patients at Discharge 
  Patients were either started on an antiplatelet therapy (mostly aspirin) or anticoagu-
lation de novo, or their antiplatelet therapy was changed from one agent to another. The 
results are presented in   table 3  . The total number of adjustments adds up to 83 because 1 
  Table 2. Baseline demographic and clinical characteristics of the patients
Group 1 
(n = 23)
Group 2 
(n = 59)
p value
Male 15 (65) 30 (50) 0.24
Age, years 67 ± 17 69 ± 14 0.68
Time from symptom onset to ED, min 145 ± 143 186 ± 224 0.42
TIA symptom duration, min 34 ± 40 42 ± 43 0.47
Length of hospitalization, days 2.13 ± 1.39 2.03 ± 0.82 0.82
Diabetes mellitus 4 (17) 17 (28) 0.32
Hypertension 17 (74) 44 (75) 0.50
Hyperlipidemia 12 (52) 39 (66) 0.24
Atrial fibrillation 6 (26) 7 (12) 0.06
Left ventricular ejection fraction <30% 2 (9) 3 (5) 0.54
Antiplatelet use prior to the event 11 (48) 27 (46) 0.86
Anticoagulant use prior to the event 7 (30) 10 (17) 0.17
Systolic blood pressure at ED, mm Hg 146 ± 20 149 ± 25 0.60
Diastolic blood pressure at ED, mm Hg 79 ± 11 75 ± 14 0.24
Values represent n (%) or mean ± SD.
  Table 3. Therapeutic adjustments and endarterectomy of the patients in group 1 and group 2
Treatment change at the time of hospital discharge Group 1 (n = 23) Group 2 (n = 59) p value
No change 8 (35) 10 (17) 0.08
Antiplatelet started 5 (22) 21 (36) 0.23
Antiplatelet changed 5 (22) 21 (36) 0.23
Anticoagulation started (ED + inpatient) 5 (22) 6 (10) 0.17
Anticoagulation started (inpatient) 1 (4) 3 (5) 0.88
Carotid endarterectomy 0 (0) 2 (3) 0.37
Values represent n (%).73 Cerebrovasc Dis Extra 2014;4:69–76
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patient had carotid endarterectomy and was switched from aspirin to clopidogrel. Arterial 
revascularization procedures were performed in 3.4% of the patients in group 2 versus 0% 
in group 1 (p = 0.27). Other therapeutic adjustments did not differ between the patients who 
were evaluated with MRI and those who were not (p > 0.05) (  table 3  ).
  Neuroimaging  Findings 
  Head CT done at the ED upon presentation did not show acute changes (early signs of 
ischemia or brain hemorrhage) in any of the 82 patients. Out of the 59 patients who were 
evaluated with diffusion-weighted MRI, 26 patients (44%) had acute small infarcts without 
changes on the neurological examination. Three of these 26 patients (11.5%) were started on 
anticoagulation after MRI had been done. One case had a stump embolus, another was 
discovered to have a hypercoagulable state and the third case had paroxysmal atrial fibril-
lation. Two patients (7.7%) had their aspirin changed to clopidogrel after the MRI scan. The 
therapeutic changes in all of these 5 patients were independent of their MRI findings. In 
patients whose MRI was normal, there were no therapeutic adjustments during inpatient 
stay. In group 1, only 1 patient with adjustment of antiplatelet at the ED was started on anti-
coagulation during inpatient stay because of atrial fibrillation on cardiac telemetry. 
  Cost-Minimization  Analysis 
  The majority of the patients in this study had CT/CTA at the ED and later MRI for further 
evaluation. The average per-patient cost of neuroimaging with CT/CTA was USD 1,460.00, 
with CT and MRI/MRA USD 1,569 and with CT/CTA and brain MRI USD 2,090.00 (p < 0.01).
    Discussion 
  Similar to other previous reports, we found that imaging TIA patients with MRI provides 
more information, such as the detection of acute small infarcts with changes in the diffusion-
weighted imaging sequence, than with CT. However, we found no difference in therapeutic 
adjustments made between TIA patients who underwent CT/CTA and those who underwent 
MRI/MRA. Performing MRI/MRA on patients who already had CT/CTA added to the overall 
cost without therapeutic value. Our results indicate that the evaluation of TIA patients with 
only one imaging modality (CT/CTA or MRI/MRA) minimizes the cost and is sufficient to 
formulate a treatment plan.
    We only performed a cost-minimization analysis but no cost-effectiveness analysis, as we 
found no difference in therapeutic adjustments based on CT- versus MRI-based imaging. 
Imaging with CT/CTA was the least costly. In general, all combinations of neuroimaging 
studies are acceptable for TIA patients, but repeating one study after another, such as evalu-
ating a patient with brain MRI after head CT, is unnecessary.
    Patients with TIA may be admitted as inpatients for evaluation or managed as outpa-
tients in dedicated TIA clinics, depending on the hospital and the country   [11, 12]  . In our 
institution, patients with TIA are admitted for observation and expedited workup. Both CT- 
and MRI-based imaging modalities are commonly used in the evaluation of patients with TIA. 
This is consistent with the current American Heart Association (AHA)/American Stroke Asso-
ciation (ASA) TIA evaluation guidelines   [1, 15, 16]  . The current AHA Get With the Guidelines 
(GWTG) and Primary Stroke Center (PSC) quality requirements recommend that patients 
presenting within 3 h of stroke symptom onset undergo brain imaging within 25 min of 
arrival at the ED   [17]  . This prompted us to limit this study to TIA patients for whom ‘code 
stroke’ was activated. Our institutional policy is to activate ‘code stroke’ for patients arriving 
within 9 h of symptom onset. We found that despite complete resolution of neurological 74 Cerebrovasc Dis Extra 2014;4:69–76
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symptoms, head CT was routinely performed at the ED   [18]  . This is in line with current 
practice in many hospitals, given the widespread availability and easy accessibility to CT (as 
opposed to MRI) and ability to meet the GWTG and PSC benchmarks   [17]  . In our cohort, all 
head CT scans were negative for acute findings. Other studies that evaluated the usefulness 
of head CT in patients with TIA reported that localization-related ischemia or hemorrhage can 
be found in a small number of patients   [2, 3]  . In TIA patients whose CT scan is unrevealing, 
workup is usually extended to include brain MRI to determine the exact cause. If MRI shows 
small ischemic infarcts, it helps to confirm the ischemic nature of patient symptoms. MRI may 
also suggest the source of embolism; multiple bilateral small infarcts may indicate a proximal 
source of embolization from the heart or the aortic arch. In this study, although a numerically 
higher proportion of patients had their therapeutic regimen changed during their inpatient 
stay after MRI had been performed, this was not significantly different between the two study 
groups   [15]  . In addition, the decision to start a new antithrombotic therapy in these patients 
was independent of their MRI results. This raises the questions of whether (1) initial head CT 
evaluation is necessary in patients with TIA and (2) TIA patients should undergo MRI even if 
CT has already been done. In our cohort, we found that additional imaging with MRI did not 
provide information that resulted in a change in therapy based on CT imaging, suggesting that 
CT/CTA may still be sufficient for TIA evaluation in most cases.
    When considering the cost, we found that the imaging combination CT + CTA + MRI had 
the highest cost (USD 2,090). The cost of evaluation with CT + MRI + MRA (USD 1,569), on the 
other hand, was comparable to that of CT + CTA (USD 1,460). In this case, if initial head CT 
was not done, the cost would be USD 237 less. Thus, making the evaluation with MRI + MRA 
less costly than that with CT + CTA. This is because MRA of the brain is a time-of-flight modality 
of noncontrast brain MRI and does not require additional study. Thus, both evaluations are 
incorporated in one CPT code and billed only once. MRA of the neck often requires contrast 
administration and is therefore billed separately. Noncontrast head CT with CTA of the head, 
on the other hand, requires contrast and is more expensive than MRI. CTA of the neck also has 
a separate CPT code   [19]  .
    Our study is limited by its retrospective nature, its lack of systematic long-term follow-up 
data and a relatively small number of patients in a single center. We only included patients 
who presented to the ED within 9 h of symptom onset. Therefore, our findings may not be 
generalizable to other centers or all TIA patients. However, the observed trend in TIA evalu-
ation where CT is almost always performed before MRI is commonly seen at several other 
hospitals in the United States. This study only accounts for the direct cost of neuroimaging, 
but not the cost of hospitalization or other diagnostic tests and treatments. Although this 
could lead to some uncertainties regarding the equivalence of the cost of additional tests 
between the study groups, it is unlikely that further tests such as telemetry and echocar-
diogram are influenced by the imaging results. In fact, we found no difference in the number 
of other diagnostic tests performed between the two groups. Lastly, we found no difference 
in the length of hospitalization between the two study groups. This likely reflects the easy 
access to and ability to perform MRI 24/7 at the ED of our institution. It is likely that the length 
of hospitalization, and therefore the overall cost could increase at other institutions where 
access to MRI is more limited.
    Conclusion 
  TIA patients should ideally be evaluated directly with MRI/MRA, if available in a timely 
manner. This is both more informative and cost-effective. Initial evaluation with head CT in 
these patients is unnecessary. If brain MRI is unavailable, evaluation with CT/CTA is still suffi-75 Cerebrovasc Dis Extra 2014;4:69–76
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cient to formulate a treatment plan. Repeating MRI following CT/CTA may reveal small 
infarcts but is unlikely to change the treatment plan and adds more to the overall cost. Future 
prospective multicenter studies with long-term follow-up data in a larger cohort of TIA 
patients are needed to better understand the safety and cost of imaging for TIA.
    Disclosure Statement 
  There are no conflicts of interest to declare.
 
  References 
   1  Easton JD, Saver JL, Albers GW, et al: Definition and evaluation of transient ischemic attack: a scientific 
statement for healthcare professionals from the American Heart Association/American Stroke Association 
Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and 
Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular 
Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for 
neurologists. Stroke 2009;     40:     2276–2293. 
   2  Koudstaal PJ, van Gijn J, Frenken CW, Hijdra A, Lodder J, Vermeulen M, Bulens C, Franke CL: TIA, RIND, minor 
stroke: a continuum, or different subgroups? Dutch TIA Study Group. J Neurol Neurosurg Psychiatry 1992;     55:   
  95–97. 
   3  Douglas VC, Johnston CM, Elkins J, Sidney S, Gress DR, Johnston SC: Head computed tomography findings 
predict short-term stroke risk after transient ischemic attack. Stroke 2003;     34:     2894–2898. 
   4  Weisberg LA: Computerized tomographic abnormalities in patients with hemispheric transient ischemic 
attacks. South Med J 1986;     79:     804–807. 
   5  Turnbull IW, Bannister CM: CT observations on the natural history of asymptomatic cerebral infarction 
following transient ischaemic attacks. Neurol Res 1985;     7:     190–193. 
   6  Coutts SB, Modi J, Patel SK, Demchuk AM, Goyal M, Hill MD: CT/CT angiography and MRI findings predict 
recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. 
Stroke 2012;     43:     1013–1017. 
   7  Purroy F, Jimenez Caballero PE, Gorospe A, et al: Prediction of early stroke recurrence in transient ischemic 
attack patients from the PROMAPA study: a comparison of prognostic risk scores. Cerebrovasc Dis 2012;     33:   
  182–189. 
   8  Smith WS, Roberts HC, Chuang NA, Ong KC, Lee TJ, Johnston SC, Dillon WP: Safety and feasibility of a CT 
protocol for acute stroke: combined CT, CT angiography, and CT perfusion imaging in 53 consecutive patients. 
AJNR Am J Neuroradiol 2003;     24:     688–690. 
   9  Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, 
Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wentworth 
D: Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for 
healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;     42:   
  227–276. 
  10  Ovbiagele B, Kidwell CS, Saver JL: Epidemiological impact in the United States of a tissue-based definition of 
transient ischemic attack. Stroke 2003;     34:     919–924. 
  11  Olivot JM, Albers GW: Diffusion-perfusion MRI for triaging transient ischemic attack and acute cerebrovas-
cular syndromes. Curr Opin Neurol 2011;     24:     44–49. 
  12  Fazekas F, Fazekas G, Schmidt R, Kapeller P, Offenbacher H: Magnetic resonance imaging correlates of tran-
sient cerebral ischemic attacks. Stroke 1996;     27:     607–611. 
  13  Bhadelia RA, Anderson M, Polak JF, Manolio TA, Beauchamp N, Knepper L, O’Leary DH: Prevalence and asso-
ciations of MRI-demonstrated brain infarcts in elderly subjects with a history of transient ischemic attack. The 
Cardiovascular Health Study. Stroke 1999;     30:     383–388. 
  14  Chatzikonstantinou A, Wolf ME, Schaefer A, Hennerici MG: Risk prediction of subsequent early stroke in 
patients with transient ischemic attacks. Cerebrovasc Dis 2013;     36:     106–109. 
  15  Amort M, Fluri F, Weisskopf F, Gensicke H, Bonati LH, Lyrer PA, Engelter ST: Etiological classifications of tran-
sient ischemic attacks: subtype classification by TOAST, CCS and ASCO – a pilot study. Cerebrovasc Dis 2012;   
  33:     508–516. 
  16  Amort M, Fluri F, Schafer J, Weisskopf F, Katan M, Burow A, Bucher HC, Bonati LH, Lyrer PA, Engelter ST: Tran-
sient ischemic attack versus transient ischemic attack mimics: frequency, clinical characteristics and outcome. 
Cerebrovasc Dis 2011;     32:     57–64. 76 Cerebrovasc Dis Extra 2014;4:69–76
  DOI: 10.1159/000360521 
EXTRA
  Sidorov et al.: Cost-Minimization Analysis of CT versus MRI in the Evaluation of 
Patients with TIA at a Large Academic Center 
www.karger.com/cee
© 2014 S. Karger AG, Basel
  17  Alberts MJ, Latchaw RE, Jagoda A, Wechsler LR, Crocco T, George MG, Connolly ES, Mancini B, Prudhomme S, 
Gress D, Jensen ME, Bass R, Ruff R, Foell K, Armonda RA, Emr M, Warren M, Baranski J, Walker MD: Revised 
and updated recommendations for the establishment of primary stroke centers: a summary statement from 
the brain attack coalition. Stroke 2011;     42:     2651–2665. 
  18  Diaz-Guzman J, Egido JA, Gabriel-Sanchez R, Barbera-Comes G, Fuentes-Gimeno B, Fernandez-Perez C: Stroke 
and transient ischemic attack incidence rate in Spain: the IBERICTUS study. Cerebrovasc Dis 2012;     34:     272–
281. 
  19  http://www.ama-assn.org/ama/pub/physician-resources/solutions-managing-your-practice/coding-
billing-insurance/cpt.page? 2012. 
  